Literature DB >> 16670636

TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock.

Milena Karina Colo Brunialti1, Paulo Sergio Martins, Heraclito Barbosa de Carvalho, Flavia Ribeiro Machado, Leandro Martins Barbosa, Reinaldo Salomao.   

Abstract

Bacterial recognition and induced cellular activation are fundamental for the host control of infection, yet the limit between protective and harmful response is still inexact. Forty-one patients were enrolled in this study: 14 with sepsis, 12 with severe sepsis, and 15 with septic shock. Seventeen healthy volunteers (HV) were included as control. The expression of TLR2, TLR4, CD14, CD11b, and CD11c was analyzed on monocytes surface in whole blood. sCD14 was measured in serum, and TNF-alpha, IL-6, and IL-10 cytokine levels were measured in PBMC supernatants after LPS, IL-1beta, and TNF-alpha stimuli by ELISA. An increase in sCD14 and a decreased mCD14 were found in patients as compared with HV (P < 0.001). However, no differences in the expression of TLR2, TLR4, and CD11c were found among the groups. A trend toward differential expression of CD11b was observed, with higher values found in patients with sepsis as compared with HV. A negative regulation of the inflammatory cytokine production was observed in patients with severe sepsis and shock septic in relation to sepsis and HV, regardless of the stimulus. No significant difference in IL-10 production was found among the groups. In this study, we show that the inflammatory response is associated with the continuum of clinical manifestations of sepsis, with a strong inflammatory response in the early phase (sepsis) and a refractory picture in the late phases (severe sepsis and septic shock). Correlation between cell surface receptors and cytokine production after IL-1beta and TNF-alpha stimuli and the observation of a single and same standard response with the different stimulus suggest a pattern of immunology response that is not dependent only on the expression of the evaluated receptors and that is likely to have a regulation in the intracellular signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670636     DOI: 10.1097/01.shk.0000217815.57727.29

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  29 in total

1.  Burkholderia pseudomallei triggers altered inflammatory profiles in a whole-blood model of type 2 diabetes-melioidosis comorbidity.

Authors:  Jodie Morris; Natasha Williams; Catherine Rush; Brenda Govan; Kunwarjit Sangla; Robert Norton; Natkunam Ketheesan
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

Review 2.  Presepsin as a novel sepsis biomarker.

Authors:  Qi Zou; Wei Wen; Xin-Chao Zhang
Journal:  World J Emerg Med       Date:  2014

3.  Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers.

Authors:  Bahareh Kashani; Zahra Zandi; Mohammad Reza Karimzadeh; Davood Bashash; Ali Nasrollahzadeh; Seyed H Ghaffari
Journal:  Immunol Res       Date:  2019-12       Impact factor: 2.829

4.  Inflammasome gene profile is modulated in septic patients, with a greater magnitude in non-survivors.

Authors:  K F Esquerdo; N K Sharma; M K C Brunialti; G L Baggio-Zappia; M Assunção; L C P Azevedo; A T Bafi; R Salomao
Journal:  Clin Exp Immunol       Date:  2017-04-20       Impact factor: 4.330

5.  Toll-like receptor 4 expression on circulating leucocytes in hemolytic uremic syndrome.

Authors:  Patricia G Vallés; Silvia Melechuck; Adriana González; Walter Manucha; Victoria Bocanegra; Roberto Vallés
Journal:  Pediatr Nephrol       Date:  2011-10-05       Impact factor: 3.714

6.  PF-04886847 (an inhibitor of plasma kallikrein) attenuates inflammatory mediators and activation of blood coagulation in rat model of lipopolysaccharide (LPS)-induced sepsis.

Authors:  D Kolte; J W Bryant; G W Gibson; J Wang; Z Shariat-Madar
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2012-06

7.  Effect of transforming growth factor-β1 on monocyte Toll-like receptor 4 expression in septic rats.

Authors:  Yu Zhang; Jing Xing
Journal:  World J Emerg Med       Date:  2011

8.  Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.

Authors:  Kendra N Iskander; Marcin F Osuchowski; Deborah J Stearns-Kurosawa; Shinichiro Kurosawa; David Stepien; Catherine Valentine; Daniel G Remick
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

9.  Chemokines mediate ethanol-induced exacerbations of murine cockroach allergen asthma.

Authors:  J C Bouchard; D R Beal; J Kim; L J Vaickus; D G Remick
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

10.  Increased expression of CD14 in macrophages after inhibition of the cholesterol biosynthetic pathway by lovastatin.

Authors:  Tiffany Frey; Antonio De Maio
Journal:  Mol Med       Date:  2007 Nov-Dec       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.